Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   Peptide hydrogels for affinity-controlled release of therapeutic cargo: Current and potential strategies
  2. Nambiar,Monessha; Schneider,Joel
  3. Journal of Peptide Science. 2021, Nov 7; e3377.
  1. 2.   A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics
  2. Price, Lauren S. L.; Stern,Steve; Deal, Allison M.; Kabanov, Alexander; Zamboni, William C.
  3. SCIENCE ADVANCES. 2020, JUL; 6(29): eaay9249.
  1. 3.   Blood Interactions, Pharmacokinetics, and Depth-Dependent Ablation of Rat Mammary Tumors with Photoactivatable, Liposomal Doxorubicin
  2. Carter, Kevin A.; Luo, Dandan; Geng, Jumin; Stern, Steve; Lovell, Jonathan F.
  3. Molecular cancer therapeutics. 2019, Mar; 18(3): 592-601.
  1. 4.   Evolution-Based Design of an Injectable Hydrogel
  2. Geisler, I. M.; Schneider, J. P.
  3. Advanced Functional Materials. 2012, Feb; 22(3): 529-537.
  1. 5.   Polymeric Lipid Assemblies as Novel Theranostic Tools
  2. Puri, A.; Blumenthal, R.
  3. Accounts of Chemical Research. 2011, Oct; 44(10): 1071-1079.
  1. 6.   Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes)
  2. Smith, B.; Lyakhov, I.; Loomis, K.; Needle, D.; Baxa, U.; Yavlovich, A.; Capala, J.; Blumenthal, R.; Puri, A.
  3. Journal of Controlled Release. 2011, Jul; 153(2): 187-194.
  1. 7.   Quantitative Analysis of Phospholipids Using Nanostructured Laser Desorption Ionization Targets
  2. Colantonio, S.; Simpson, J. T.; Fisher, R. J.; Yavlovich, A.; Belanger, J. M.; Puri, A.; Blumenthal, R.
  3. Lipids. 2011, May; 46(5): 469-477.
  1. 8.   Supramolecular complexes of quantum dots and a polyamidoamine (PAMAM)-folate derivative for molecular imaging of cancer cells
  2. Geraldo, D. A.; Duran-Lara, E. F.; Aguayo, D.; Cachau, R. E.; Tapia, J.; Esparza, R.; Yacaman, M. J.; Gonzalez-Nilo, F. D.; Santos, L. S.
  3. Analytical and Bioanalytical Chemistry. 2011, Apr; 400(2): 483-492.
  1. 9.   Nanotechnology-Based Cancer Therapeutics-Promise and Challenge-Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
  2. Farrell, D.; Ptak, K.; Panaro, N. J.; Grodzinski, P.
  3. Pharmaceutical Research. 2011, Feb; 28(2): 273-278.
  1. 10.   A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubcin to cells
  2. Yavlovich, A.; Singh, A.; Blumenthal, R.; Puri, A.
  3. Biochimica Et Biophysica Acta-Biomembranes. 2011, Jan; 1808(1): 117-126.
  1. 11.   Informatics and standards for nanomedicine technology
  2. Thomas, D. G.; Klaessig, F.; Harper, S. L.; Fritts, M.; Hoover, M. D.; Gaheen, S.; Stokes, T. H.; Reznik-Zellen, R.; Freund, E. T.; Klemm, J. D.; Paik, D. S.; Baker, N. A.
  3. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology. 2011, Sep-Oct; 3(5): 511-532.
  1. 12.   The effect of protein structure on their controlled release from an injectable peptide hydrogel
  2. Branco, M. C.; Pochan, D. J.; Wagner, N. J.; Schneider, J. P.
  3. Biomaterials. 2010, Dec; 31(36): 9527-9534.
  1. 13.   Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates
  2. Nwe, K.; Bernardo, M.; Regino, C. A. S.; Williams, M.; Brechbiel, M. W.
  3. Bioorganic & Medicinal Chemistry. 2010, Aug; 18(16): 5925-5931.
  1. 14.   Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-(AuNP)-Au-198 nanoconstruct in prostate tumor-bearing mice
  2. Chanda, N.; Kan, P.; Watkinson, L. D.; Shukla, R.; Zambre, A.; Carmack, T. L.; Engelbrecht, H.; Lever, J. R.; Katti, K.; Fent, G. M.; Casteel, S. W.; Smith, C. J.; Miller, W. H.; Jurisson, S.; Boote, E.; Robertson, J. D.; Cutler, C.; Dobrovolskaia, M.; Kannan, R.; Katti, K. V.
  3. Nanomedicine-Nanotechnology Biology and Medicine. 2010, Apr; 6(2): 201-209.
  1. 15.   Stabilization of the Nitric Oxide (NO) Prodrugs and Anticancer Leads, PABA/NO and Double JS-K, through Incorporation into PEG-Protected Nanoparticles
  2. Kumar, V.; Hong, S. Y.; Maciag, A. E.; Saavedra, J. E.; Adamson, D. H.; Prud'homme, R. K.; Keefer, L. K.; Chakrapani, H.
  3. Molecular Pharmaceutics. 2010, Jan-Feb; 7(1): 291-298.
  1. 16.   Nanoparticle therapeutics: a personal perspective
  2. McNeil, S. E.
  3. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology. 2009, May-Jun; 1(3): 264-271.
  1. 17.   Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles
  2. Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J. W.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E.
  3. Nanomedicine-Nanotechnology Biology and Medicine. 2009 5(2): 106-117.
  1. 18.   Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
  2. Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; McNeil, S. E.
  3. Molecular Pharmaceutics. 2008 5(4): 487-495.
  1. 19.   HER2-Specific Affibody-Conjugated Thermosensitive Liposomes (Affisomes) for Improved Delivery of Anticancer Agents
  2. Puri, A.; Kramer-Marek, G.; Campbell-Massa, R.; Yavlovich, A.; Tele, S. C.; Lee, S. B.; Clogston, J. D.; Patri, A. K.; Blumenthal, R.; Capala, J.
  3. Journal of Liposome Research. 2008 18(4): 293-307.
  1. 20.   Design and synthesis of paclitaxel conjugated with an ErbB2-Recognizing pepticle, EC-1
  2. Li, P.; Jiang, S.; Pero, S. C.; Oligino, L.; Krag, D. N.; Michejda, C. J.; Roller, P. P.
  3. Biopolymers. 2007, Nov; 87(4): 225-230.
  1. 21.   Immunological properties of engineered nanomaterials
  2. Dobrovolskaia, M. A.; McNeil, S. E.
  3. Nature Nanotechnology. 2007, Aug; 2(8): 469-478.
  1. 22.   Analysis of fullerene-based nanomaterial in serum matrix by CE
  2. Chan, K. C.; Patri, A. K.; Veenstra, T. D.; McNeil, S. E.; Issaq, H. J.
  3. Electrophoresis. 2007, May; 28(10): 1518-1524.
  1. 23.   Poly(ethylene glycol) prodrugs of the CDK inhibitor, alsterpaullone (NSC 705701): Synthesis and pharmacokinetic studies
  2. Greenwald, R. B.; Zhao, H.; Xia, J.; Wu, D. C.; Nervi, S.; Stinson, S. F.; Majerova, E.; Bramhall, C.; Zaharevitz, D. W.
  3. Bioconjugate Chemistry. 2004, SEP-OCT; 15(5): 1076-1083.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel